Pamela Vergara‐Rodriguez

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

Frederick L. Altice, R. Douglas Bruce, Gregory M. Lucas et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 259 citations

Pharmacy, Pharmacotherapy, Outcomes Research +16

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use

Lisa R. Metsch, Daniel J. Feaster, Lauren Gooden et al. · JAMA · 2016 · 193 citations · Full text

Public Health, Infectious Disease Control, Health Services Research +11

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

P. Todd Korthuis, Paula J. Lum, Pamela Vergara‐Rodriguez et al. · Addiction · 2017 · 60 citations

Public Health, Pharmacotherapy, Clinical Pharmacology +13

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

P. Todd Korthuis, Ryan Cook, Paula J. Lum et al. · Addiction · 2022 · 24 citations · Full text

Nursing, Clinical Pharmacy, Pharmacotherapy +15

Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients

Pamela Vergara‐Rodriguez, Mary Jo Tozzi, Michael Botsko et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +17